About this role
DUPIXENT Health Economics and Value Assessment Business Partner - VIE Contract Location: United States of America, Cambridge Target start date: 01/01/2027 iMove, the Sanofi VIE Program, is available to citizens of the European Economic Area (EU + Norway, Liechtenstein and Iceland) aged between 18 and 28. PLEASE NOTE that since this program is primarily an international development program, candidates cannot apply to a VIE assignment in their own country of citizenship. PLEASE NOTE that applications that are only submitted in French cannot be considered by our non-French speaking partners at Sanofi worldwide.
Therefore, only applications that are submitted in English will be considered. Please make sure to apply with your personal email address. About the job As DUPIXENT Health Economics and Value Assessment Business Partner VIE within our Market Access team, you will contribute significantly, both in quantity and quality, to scientific work that the HEVA (Health Economics and Value Assessment) Respiratory/Rhinology/GI team delivers.
DUPIXENT is the flagship of the Sanofi Specialty Care life changing Immunology Franchise. It is currently being launched worldwide for conditions including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis and prurigo nodularis, with the ambition of becoming the treatment of choice for all type 2 inflammation diseases due to its innovative mode of action. The portfolio for this product includes 10+ indications currently being evaluated at various stages of clinical development.
Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. Ready to get started?
About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.
Main responsibilities: Manage and execute health economics and outcomes research (HEOR) studies to support the clinical, economic, and humanistic value propositions of dupilumab across respiratory, rhinology and GI indications. Such studies may include core value dossier/ Academy of Managed Care Pharmacy (AMCP) dossier, burden of illness, epidemiology, literature review, real-world evidence, meta-analysis, economic models, and patient-reported outcomes. Support contracting and project management activities.
Set evidence generation priorities and direction for assigned responsibilities and incorporate them into daily practice. Support the Integrated Evidence Generation Plan and Brand Planning processes, supervised by HEVA Business Partners. Develop and maintain collegial relationships with internal cross-functional global/US stakeholders and external alliance partners.
A bout you Experience: At least 1 year of previous experience in connection with this field. Previous experience in Health Economics and Outcomes Research or Health Services Research would be a plus. Solid experience with HEOR methodologies and applications is appreciated.
Soft and technical skills: Effective communication skills, both written and verbal, including presentation skills. Agility and flexibility to adapt to ways of working within the organization. Strong ability to partner with colleagues from other functional areas (Market Access & Pricing, Medical Affairs, Commercial).
Knowledge of and experience with Global Health Technology Assessment (HTA), processes and guidelines, submissions preferred. Proficiency in principles of evidence-based medicine and clinical research. Education: Master’s degree in Health Economics and Outcomes Research (HEOR)-related scientific disciplines or similar field.
Languages: Fluent English (written and verbal). Why choose us? Be part of a pioneering biopharma company where patient insights shape drug development.
Work at the forefront of AI-powered science that accelerates discovery and improves outcomes. Collaborate beyond your expertise, sparking new ideas with diverse, multidisciplinary teams. iMove is a unique program tailored for European youth interested in challenging themselves with meaningful assignments across the globe. At Sanofi we have a strong ambition to invest in young talents who will drive the success of Sanofi tomorrow.
Sanofi’s Work Abroad Program, iMove, offers jobs-assignments with actual responsibilities and a perspective to grow. We provide those opportunities in various functions such as: marketing, finance, regulatory, supply chain, clinical trials, production, etc. and in more than 40 countries. Sanofi unites people who are passionate about solving healthcare needs across the world.
Joining our iMove Work Abroad Program is a unique opportunity to make a difference through your work. #LI-EUR Pursue progress , discover extraordinary Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen.
So, let’s be those people. Sanofi US endeavours to make our career center accessible to any and all users. If you are experiencing difficulty and need assistance applying online, please call 1-866-SANOFI2 (1-866-726-6342) or click here US and Puerto Rico Residents Only Sanofi Inc. and its U.S. affiliates are Equal Opportunity employers committed to a culturally inclusive workforce.
All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.